Nectar Lifesciences extends slump sale completion date of its empty hard gelatin capsule business to on or before July 31, 2026.
The sale is to Capnest Health Care Private Limited, with all other terms from the original December 2025 agreement remaining unchanged.
Disclosure is made pursuant to SEBI LODR Regulation 30, continuing previous communications about the business transfer.